GS

Oct 10 2024HEALTH

Weight Loss Drugs: Not Covered by Most Large Companies

Looking into how many large companies cover weight loss drugs, a recent Health Affairs survey reveals a surprising truth. Less than one in five of these big firms include popular, pricey drugs like Wegovy and Zepbound in their health plans. This leaves millions of workers without access to these med

reading time less than a minute
Oct 10 2024SPORTS

Fantasy Football: Top Wide Receivers to Watch in Week 6

Welcome to week 6 of fantasy football! Let's take a look at some must-start wide receivers who should shine this week. Jalen Tolbert from the Dallas Cowboys is one of the players to watch. He scored a touchdown against the Pittsburgh Steelers and may have more opportunities with Brandin Cooks out. F

reading time less than a minute
Oct 09 2024SPORTS

The Last Coaches Standing: Dan Campbell and Nick Sirianni

In 2021, the NFL welcomed seven new head coaches. Five years later, only two remain. With the firing of Robert Saleh, it leaves Dan Campbell of the Lions and Nick Sirianni of the Eagles as the last coaches from that class still standing. The first to go was Urban Meyer, a legendary college coach wh

reading time less than a minute
Oct 09 2024FINANCE

Investment Predictions: A Tech Duo in the Spotlight

In the ever-evolving world of technology, two companies have recently attracted attention from analysts. Infineon Technologies AG and Atlassian are both getting positive vibes from experts in the field. Starting with Infineon, a key player in the tech sector, Bernstein analyst Sara Russo gave it th

reading time less than a minute
Oct 09 2024FINANCE

Investors' Take on Tech Giants: Itron and Logitech

Tech companies are in the spotlight today, as experts share their views on Itron and Logitech. Starting with Itron, their stock price is soaring, recently closing at $105.77, just shy of its highest point this year at $113.07. One analyst, Osborne, has a great track record, with an average return of

reading time less than a minute
Oct 09 2024HEALTH

Slimming Drugs: The New Weight Loss Phenomenon

Ever heard of a drug that can help you shed pounds while treating diabetes? Well, meet Ozempic, Wegovy, and Zepbound – the weight loss drugs taking the world by storm. Originally designed to treat diabetes, these medications have a slimming side effect that's got everyone talking. Pharmaceutical gia

reading time less than a minute
Oct 08 2024BUSINESS

Pepsi's Challenges: Lower Profits and New Predictions

PepsiCo has adjusted its expectations for 2024, forecasting a smaller increase in organic revenue due to several issues. Problems like recalled Quaker Foods products, reduced U.S. demand, and international business disruptions have led to weaker-than-expected sales. Pepsi now expects a low-single-di

reading time less than a minute
Oct 08 2024BUSINESS

Samsung's AI Setback: What Went Wrong and What's Next?

Samsung is having a rough patch in the AI chip market, especially with its HBM segment. The company admitted it couldn't land a major client like NVIDIA. This delay, along with increased competition from rivals like SK hynix and TSMC, hurt Samsung's earnings. Samsung blames its late entry into the

reading time less than a minute
Oct 08 2024HEALTH

US to Screen Travelers from Rwanda for Marburg Virus

Hey there! Ever heard of Marburg? It’s a nasty virus that can cause fever, bleeding, and serious health issues, similar to Ebola. Well, starting mid-October, the US is going to start checking passengers who've been in Rwanda recently. These travelers will go through specific airports like Chicago O’

reading time less than a minute
Oct 08 2024HEALTH

Do Antidepressant Warnings Help or Hurt Kids?

For years, the FDA has warned that antidepressants might lead to suicidal thoughts in youth. But new research shows these warnings might have backfired. They could have caused fewer doctor visits for depression and more suicide attempts. This is a big deal because depression is a top cause of suicid

reading time less than a minute